SonaCare Medical's Sonablate 450 ultrasound device has received de novo clearance by the FDA for ablation of prostate tissue.
Anthony Berberabe, MPH
Advertisement
Articles by Anthony Berberabe, MPH
Advertisement
Latest Updated Articles
Ultrasound Device Receives FDA Clearance for Prostate CancerPublished: October 20th 2015 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Managing Acute and Late Adverse Effects of Breast Cancer Radiation
2
An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team
3
Osimertinib/Chemo Boosts OS in EGFR+ NSCLC With Poor Prognosis
4
Improving Access to Supportive Care on an Organizational Level With Korie Bigbee
5
